Loading clinical trials...
Loading clinical trials...
Rationale: Beside Candida and Aspergillus, emerging invasive fungal infections (EIFIs) are increasing in intensive care setting and are associated with high morbidity and mortality. However, data are ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University Hospital, Montpellier
NCT06510699 · Fungal Infection, Haematological Malignancy, and more
NCT07167121 · ICU Acquired Weakness, Intensive Care Neuropathy
NCT04665037 · Invasive Fungal Infection
NCT06105411 · Invasive Fungal Infections
NCT06537726 · Leukemia, Leukemia, Myeloid, and more
Uhmontpellier
Montpellier
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions